This can lead to ineffective benefits in both weight and blood sugar control
Return of Cravings Some patients notice an increase in cravings, particularly for highly processed or energy dense foods
That means if you think you are injecting 0.5 mg, you might actually be getting 0.3 mg, a dose too low to produce meaningful appetite suppression or weight loss
To query whether weight loss by incretin agonism would impact cancer outcomes in pre-clinical models, we studied the impact of medical weight loss on two deadly cancers including pancreatic ductal adenocarcinoma (PDAC) and lung adenocarcinoma (LUAD) as either obesity-associated or obesity-independent cancers, respectively
Expect Side Effects: Side effects can be nausea, constipation, or diarrhea
The key differences lie in the range of medications offered, dosing flexibility, and how medical care is integrated with ongoing behavior support